NCT06504615View on ClinicalTrials.gov

Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions
Gastric AdenocarcinomaGastro-esophageal Junction AdenocarcinomaEsophageal Adenocarcinoma (EAC)Esophageal Squamous Cell Carcinoma (ESCC)
Interventions
DRUG

nivolumab + chemotherapy

As prescribed by the treating clinician, as per product label

Trial Locations (2)

75002

RECRUITING

KAPPA SANTE Institution, Paris

Unknown

NOT_YET_RECRUITING

Kappa Santé, Paris

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06504615 - Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France | Biotech Hunter | Biotech Hunter